Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Colon Cancer
"Chemoprevention of Colon Cancer by Organoselenium Compounds and Impact of High- or Low-Fat Diets."
May 26th, 1997
According to the authors' abstract of an article published in Journal of the National Cancer Institute, "Background: Observational and experimental studies have suggested that dietary supplementation with selenium can inhibit the development of colon cancer. However, many forms of selenium are toxic. Consequently, the development of efficacious compounds with low toxicity has been pursued, Purpose: Two synthetic organoselenium compounds, p-methoxy-benzyl selenocyanate (p-methoxy-BSC) and 1,4-phenylenebis(methylene)selenocyanate (p-XSC), were tested for their ability to inhibit colon carcinogenesis in rats that were treated with the carcinogen azoxymethane and fed low-...
Source: Cancer Weekly (1997-05-26)
|
|
Advertisement |
|
|
